# PREDICT-SpA - French Epidemiological Study of the Evaluation of the Impact of Fibromyalgia in the TNF Alpha Treatment Effect in Axial Spondyloarthritis in Both Anti-TNF naïve and - Experienced Patients

> **NCT03039088** · — · COMPLETED · sponsor: **Association de Recherche Clinique en Rhumatologie** · enrollment: 527 (actual)

## Conditions studied

- Axial Spondyloarthritis
- Fibromyalgia

## Interventions

- **OTHER:** Follow-up after 12 weeks after TNF alpha blockers initiation

## Key facts

- **NCT ID:** NCT03039088
- **Lead sponsor:** Association de Recherche Clinique en Rhumatologie
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10-02
- **Primary completion:** 2016-10-04
- **Final completion:** 2016-10-04
- **Target enrollment:** 527 (ACTUAL)
- **Last updated:** 2018-09-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03039088

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03039088, "PREDICT-SpA - French Epidemiological Study of the Evaluation of the Impact of Fibromyalgia in the TNF Alpha Treatment Effect in Axial Spondyloarthritis in Both Anti-TNF naïve and - Experienced Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03039088. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*